JSPR (STOCKS)
Jasper Therapeutics, Inc. Common Stock
$0.920100
+0.117800 (+14.68%)
Prev close: $0.802300
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jeet Mahal
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $25.28M
- Employees
- 64
- P/E (TTM)
- -0.17
- P/B (TTM)
- 5.41
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
7
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.32 | $-0.76 | +0.4392 | +57.85% |
|
Sep 2025 (Q3)
|
$-1.25 | $-1.24 | -0.0108 | -0.87% |
|
Jun 2025 (Q2)
|
$-1.74 | $-1.35 | -0.3870 | -28.60% |
|
Mar 2025 (Q1)
|
$-1.41 | $-1.34 | -0.0712 | -5.32% |
Financial Statements
| Revenues | $0.00 |
| Cost Of Revenue | $41.64M |
| Nonoperating Income/Loss | $8.08M |
| Operating Expenses | $83.88M |
| Depreciation and Amortization | $1.06M |
| Research and Development | $63.10M |
| Other Operating Expenses | $19.72M |
| Operating Income/Loss | -$83.88M |
| Income/Loss From Continuing Operations After Tax | -$75.80M |
| Income/Loss From Continuing Operations Before Tax | -$75.80M |
| Net Income/Loss | -$75.80M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$75.80M |
| Net Income/Loss Available To Common Stockholders, Basic | -$75.80M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.95 |
| Diluted Earnings Per Share | -$3.95 |
| Basic Average Shares | 19,168,110 |
| Diluted Average Shares | 19,168,110 |
| Assets | $35.78M |
| Current Assets | $34.65M |
| Noncurrent Assets | $1.13M |
| Fixed Assets | $102.00K |
| Other Non-current Assets | $1.03M |
| Liabilities | $31.63M |
| Current Liabilities | $13.20M |
| Accounts Payable | $6.22M |
| Wages | $1.59M |
| Other Current Liabilities | $5.39M |
| Noncurrent Liabilities | $18.43M |
| Equity | $4.15M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $4.15M |
| Liabilities And Equity | $35.78M |
| Net Cash Flow From Operating Activities | -$77.16M |
| Net Cash Flow From Operating Activities, Continuing | -$77.16M |
| Net Cash Flow From Investing Activities | $5.00K |
| Net Cash Flow From Investing Activities, Continuing | $5.00K |
| Net Cash Flow From Financing Activities | $34.21M |
| Net Cash Flow From Financing Activities, Continuing | $34.21M |
| Net Cash Flow | -$42.95M |
| Net Cash Flow, Continuing | -$42.95M |
| Comprehensive Income/Loss | -$75.80M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$75.80M |
| Other Comprehensive Income/Loss | $0.00 |